The Investor Relations website contains information about Eli Lilly and Company's business for stockholders, potential investors, and financial analysts.
Lilly's capital commitments to expand manufacturing in its home state now total $21 billion since 2020
Lilly Lebanon Advanced Therapies opens as company's first dedicated genetic medicine manufacturing facility
LEBANON, Ind., May 6, 2026 /PRNewswire/... [33803 chars]